References
1) Carapetis JR, McDonald M, Wilson NJ (2005) Acute rheumatic fever.
Lancet 366: 155-168.
2) Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global
burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694.
3) Rheumatic fever and rheumatic heart disease: report of a WHO Expert
consultation, Geneva, 29 October–1 November 2001. Geneva: World Health
Organization, 2004.
4) Australian Institute of Health and Welfare (2004) Rheumatic heart
disease: all but forgotten in Australia except among Aboriginals and
Torres Strait Islander Peoples, Australian Institute of Health and
Welfare, Canberra 2004.
5) Australian Institute of Health and Welfare (2005) The health and
welfare of Australia’s Aboriginal and Torres Strait Islander Peoples,
Australian Institute of Health and Welfare, Canberra 2005.
6) Gruen RL, Bailie RS, d’Abbs PH, O’Rourke IC, O’Brien MM, Verma N
(2001) Improving access to specialist care for remote Aboriginal
communities: evaluation of a specialist outreach service, Med J Aust 174
(10): 507–511.
7) Salustri A, Trambaiolo P (2002) Point-of-care echocardiography:
small, smart and quick, Eur Heart J 23 (19): 1484–1487.
8) Carapetis JR, Powers JR, Currie BJ, Sangster JF, Begg A, Fisher DA,
Kilburn CJ, Burrow JNC (2000) Outcomes of cardiac valve replacement for
rheumatic heart disease in Aboriginal Australians, Asia Pacific Heart J
8 (3):138–147.
9) Gill JM, Landis MK (2002) Benefits of a mobile, point-of-care
anticoagulation therapy management program, Jt Comm J Qual Improv 28
(11): 625–630.
10) Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson
J, Maguire G, Marijon E, Mirabel M, Mocumbi AO (2012) World Heart
Federation criteria for echocardiographic diagnosis of rheumatic heart
disease–an evidence-based guideline. Nat Rev Cardiol 9: 297–309.
11) Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B,
Mocumbi AO, Paquet C, Sidi D, Jouven X (2009) Rheumatic heart disease
screening by echocardiography: The inadequacy of world health
organization criteria for optimizing the diagnosis of subclinical
disease. Circulation 120(8): 663–668.
12) El Aroussy WA, ElHagracy N, Fawzi H, Zaher S, Taha N, Moustafa S
(2014). Prevalence of Rheumatic Valvular Heart Disease Among Egyptian
School Children. Echocardiographic and Doppler Screening. Global Heart
9(1): 299.
13) Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH (2017)
Community-based prevalence study of rheumatic heart disease in rural
Ethiopia. European journal of preventive cardiology 24(7):717-723.
14) Jaffe WM, Roche AH, Coverdale HA, McAlister HF, Ormiston JA, Greene
ER (1988) Clinical evaluation versus Doppler echocardiography in the
quantitative assessment of valvular heart disease. Circulation
78(2):267-275.